Navigation Links
University of Pittsburgh researchers crack code of 3-D structure in key metabolic protein
Date:3/10/2008

e to the interior of the cell. As a result, it is technically challenging to produce enough highly purified and active protein to obtain clear, relevant information about the enzymes atomic structure. This study marks the highest resolution structure of a monotopic membrane protein that scientists have solved to date, and is one of only a handful of structures of this important class of membrane proteins that have been determined.

These findings and data help to fill an important scientific and technical gap in the structural field and present new information and ideas about how the enzyme works and the importance of the cell membrane in stabilizing the enzyme and in processes related to energy production, said Dr. Yeh, who published the paper along with postdoctoral research associate Unmesh N. Chinte, Ph.D., and research assistant professor, Shoucheng Du, Ph.D., both in Pitts Department of Structural Biology.

Studying the proteins and enzymes involved in oxidative and glycerol metabolism, as well as characterizing their structures, functions and regulatory relationships, has been a major research interest of Dr. Yehs lab. It took Dr. Yeh and her colleagues only three months an unusually short time to decipher the set of 3-D structures of GlpD isolated from E. coli bacteria, thanks to other methodologies they developed in earlier studies.

Rather than make conclusions based on a single structure, the team additionally determined the structures of GlpD bound with its metabolic product and several substrate analogues to evaluate the enzyme in its native and combined forms. By careful unraveling of this collection of structures, researchers could gain a more complete understanding of how the enzyme functions, details about how GlpD interacts with the membrane, works to catalyze the enzymatic reaction, and links to cellular-energy production.

As part of these challenging studies, the Pitt researchers used novel peptide-based deter
'/>"/>

Contact: Michele Baum
BaumMD@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Case Western Reserve University researchers identify colorectal cancer gene
2. New research from the University of Bristol aims to eliminate Streptococcus infections
3. Iowa State University researcher identifies eye disease in canines
4. Robert H. Smith Feeding the Future with $15 Million Gift to Hebrew University of Jerusalem
5. AT&T Provides In-Building Wireless Services to Thomas Jefferson University and Hospital
6. St. Louis University Hospital Purchases Second CyberKnife(R) System
7. Loma Linda University Medical Center Celebrates Groundbreaking on Inland Empires Most Comprehensive Rehabilitation Center
8. Alimera Sciences Signs Second Agreement With Emory University for Potential Treatments Using New Class of Antioxidants
9. University of Sydney researchers find new evidence linking kava to liver damage
10. University of Denver bullying victimization study
11. The Northern Illinois University Murders Due to Chemical Imbalances or Chemical Balancers - Drugs? - Fred A. Baughman Jr., MD, Neurologist/Child Neurologist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...NGE COUNTY, Calif., Nov. 21 Album ...ting firm, launches a new program offering big bra...have taken the large, expensive ad agency process ...s with a very hands-on approach," says Matt Parker... 2002, combines experience and proven brand-buildi...
(Date:11/21/2008)...USTON(Nov. 21, 2008)The University of Texas Health...am, Training Excellence in Aging Studies (TEXAS), ...ugh a prestigious $2 million award from the Donald...ing funds., "This will allow us to teach geriatri...nior medical student to practicing physicians. Wit...
(Date:11/21/2008)... researchers remain cautious about future antibiot...FRIDAY, Nov. 21 (HealthDay News) -- People with mo...ease (COPD) may be able to reduce the frequency of...mmon antibiotic, a new report says. , The stud...e American Journal of Respiratory and Critical Ca...
(Date:11/21/2008)...LADELPHIA, Nov. 21 NursingCenter.c...g education and peer reviewed content, has been,u...ts 350,000 registered,users. Powered by Lippincot...now,provides over 900 peer-reviewed continuing ed...cles from more than 50 leading nursing journals.,...
Breaking Medicine News(10 mins):Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3
...ten years since the Transplantation of Human Organ...adway with the programme. This has been due to var...f direction and the will to seriously consider thi...tion. There has been a lack of initiative from th...
...ording to a study published in the August issue of...troke patients are admitted to and discharged from...nts significantly. Studies have shown that several...e// the amount of disability, complications and th...
...osure to cosmic radiations while flying may increa...s, in comparison to non-pilots. The research was p...es of Ophthalmology. Commercial airline pilots are...or some cancers, but studies on the biological eff...
...ording to a recent study researchers say that they... of prostate tumour cells in laboratory settings. ...nce of prostate cancer // could be due to a rapid ...y acids in the western diet in recent years. Omega...
Other Medicine News:Health News:The Potential Of Cadaver Transplantation Programme In India 2Health News:The Potential Of Cadaver Transplantation Programme In India 3Health News:Simple Procedural Improvements Can Improve Care Of Stroke Patients 2Health News:Airlines Pilot At Heightened Risk Of Having Cataracts, 2
(Date:11/20/2008)...RNewswire/ -- New Jersey American Water has lifte...ustomers in the following municipalities in Middle...esex County , , , Dunellen , ... South Plainfield , , , , Some... Bridgewater , Green Brook , Hill...
(Date:11/20/2008)...PRNewswire-FirstCall/ -- Bionovo, Inc.,(Nasdaq: ... from the Phase 1B,clinical trial of their lead d...er, BZL101, at the Society for Integrative Oncolog...orgia. The Company,s oral presentation was select...d as a part of the Best of the,SIO Session on Nov...
(Date:11/20/2008)...20 The Scandinavian-based drug,de...sults of studies on its,lead antimicrobial candid...,the studies showed that the novel lytic peptidom...ignificantly better towards killing Staphylococcus...gold standard drugs. In,addition to this it has p...
(Date:11/19/2008)...PRNewswire/ -- Biotech scientists increasingly are...arch to better understand the effects of novel dru...s Genetic Engineering & Biotechnology News (... out a new compound,s mechanism of action and even...e, according to the November 15 issue of GEN . ( ...
Breaking Medicine Technology:New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Existing anti obesity drugs may be effective against flu hepatitis and HIV 26837 1Existing anti obesity drugs may be effective against flu hepatitis and HIV 26837 2Existing anti obesity drugs may be effective against flu hepatitis and HIV 26837 3Existing anti obesity drugs may be effective against flu hepatitis and HIV 26837 4Older Problem Gamblers Face Increased Suicide Risk 26835 1Older Problem Gamblers Face Increased Suicide Risk 26835 2Hearing Officer Secretary Ray Marshall to Set Additional Date 28s 29 for United Healthcare Workers West Trusteeship Hearing 26831 1Hearing Officer Secretary Ray Marshall to Set Additional Date 28s 29 for United Healthcare Workers West Trusteeship Hearing 26831 2Updated MD CARE Act Receives Final Congressional Approval 26827 1Updated MD CARE Act Receives Final Congressional Approval 26827 2
...condary endpoints of,study; no negative drug-drug ...d ribavirin ~, CAMBRIDGE, Mass., June 12, 2007 /PR.... today announced results from a phase II study,de...sisting of,valopicitabine (NM283), Idenix,s lead d...gylated interferon and ribavirin,compared to pegyl...
...2007 - Geron,Corporation,s (Nasdaq:GERN) telomeras... good pharmacokinetics and tolerability in,its ong...nic,lymphocytic leukemia (CLL), according to data ...e company,s president, oncology, at,the Pan Pacifi...Pharmacokinetics; Pharmacodynamics Consistent with...
Other Medicine Technology:Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good,Pharmacokinetics and Tolerability in Phase I/II Trial 2Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good,Pharmacokinetics and Tolerability in Phase I/II Trial 3Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good,Pharmacokinetics and Tolerability in Phase I/II Trial 4
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
Medicine Products: